These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 20677263

  • 1. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA.
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [Abstract] [Full Text] [Related]

  • 2. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW.
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [Abstract] [Full Text] [Related]

  • 3. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E, Pizzolato R, De Paoli L, Angileri R, Ukmar M, Cova MA.
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [Abstract] [Full Text] [Related]

  • 4. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
    Korpraphong P, Leyendecker JR, Hildebolt CF, Narra V, Bae KT, Brown JJ.
    J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
    [Abstract] [Full Text] [Related]

  • 5. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 6. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.
    Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, Diflo T, John D, Teperman LW, Goldenberg AS.
    Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156
    [Abstract] [Full Text] [Related]

  • 7. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [Abstract] [Full Text] [Related]

  • 8. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [Abstract] [Full Text] [Related]

  • 9. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU, Semelka RC, Pamuklar E, Firat Z, Gerber RD, Shrestha R, Russo MW.
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [Abstract] [Full Text] [Related]

  • 10. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, Han JK, Choi BI.
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MRI findings of rapidly progressive hepatocellular carcinoma.
    Kierans AS, Leonardou P, Hayashi P, Brubaker LM, Elazzazi M, Shaikh F, Semelka RC.
    Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
    [Abstract] [Full Text] [Related]

  • 13. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
    Chou CT, Chen YL, Su WW, Wu HK, Chen RC.
    J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
    [Abstract] [Full Text] [Related]

  • 14. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
    Gatto A, De Gaetano AM, Giuga M, Ciresa M, Siciliani L, Miele L, Riccardi L, Pizzolante F, Rapaccini GL, Gasbarrini A, Giuliante F, Vecchio FM, Pompili M, Bonomo L.
    Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 19. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK, Lee YH, Kwak HS, Kim CS, Han YM.
    Clin Imaging; 2008 Feb; 32(6):453-9. PubMed ID: 19006774
    [Abstract] [Full Text] [Related]

  • 20. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging.
    van den Bos IC, Hussain SM, Terkivatan T, Zondervan PE, de Man RA.
    J Magn Reson Imaging; 2006 Nov; 24(5):1071-80. PubMed ID: 17024654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.